Clin2
NCT04187820Possibly a fitRecruiting

Acupuncture for mild to moderate Crohn’s flare

Intestinal DisorderInflammatory Bowel DiseasesCrohn Disease

Part of Digestive system clinical trials.

This trial tests whether acupuncture can help calm an active Crohn’s disease flare that is mild to moderate. It may be an option if standard Crohn’s medicines like steroids, immunosuppressors, and anti-TNF drugs are not working for you or you can’t tolerate them.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
16 years to 70 years
Study type
Interventional

Who can take part

  • You’re between 16 and 70 years old
  • Your Crohn’s is currently mild to moderate (active symptoms)
  • You have tried key Crohn’s medicines but they didn’t work, weren’t tolerated, or you refused/needed to stop them
  • You have never had acupuncture before
  • You’re not pregnant and not breastfeeding
  • Your condition does not include serious bowel complications that could make acupuncture unsafe or interfere with results

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06553053Recruiting
Acupuncture to prevent Crohn's disease relapse

This trial tests if acupuncture can help people with Crohn's disease stay in remission longer and avoid flare-ups. If you are in remission but have had frequent relapses, this study may be for you.

Shanghai
NCT06953791Recruiting· Phase 2
Comparing two treatments for Crohn's disease flare-ups

This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.

Tübingen
NCT06146816Recruiting
Infrared light therapy for Crohn's disease

This trial tests a new infrared light treatment to see if it can reduce inflammation and symptoms in people with Crohn's disease. It's for those who have active disease despite current treatments or who are not on therapy.

Tel Aviv
NCT04263831Recruiting· Phase 1/Phase 2
Low-dose IL-2 to treat Crohn’s disease flare-ups

This trial tests a low dose of IL-2 to reduce inflammation and help control Crohn’s disease symptoms. It’s for people whose Crohn’s disease hasn’t responded to at least one standard treatment or who need steroids to stay under control.

Boston, Massachusetts
NCT06615765Not yet recruiting
Acupuncture for mild to moderate ulcerative colitis

This study tests whether acupuncture can help reduce symptoms like diarrhea and blood in stool for people with mild to moderate ulcerative colitis. It is a non-drug treatment that may be added to your usual therapy with mesalamine.

NCT07389824Recruiting
Acupuncture plus mesalazine for ulcerative colitis

This study tests whether adding acupuncture (using small intradermal needles) to the standard medication mesalazine improves outcomes for people with mild-to-moderate ulcerative colitis. Participants receive 12 acupuncture sessions and undergo two colonoscopies to assess the treatment's effect.

Wuhan, Hubei

Hear when a new Intestinal Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.